Human donor bone marrow cells can enhance hyporeactivity in renal transplantation using maintenance FK 506 and OKT3 induction therapy

Transplant Proc. 1996 Apr;28(2):943-4.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Bone Marrow Transplantation*
  • Combined Modality Therapy
  • Flow Cytometry
  • Follow-Up Studies
  • Graft Rejection / pathology
  • Graft Rejection / prevention & control
  • Histocompatibility Testing
  • Humans
  • Immunosuppression Therapy / methods*
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / pathology
  • Lymphocyte Culture Test, Mixed
  • Lymphocyte Depletion
  • Methylprednisolone / therapeutic use
  • Muromonab-CD3 / therapeutic use*
  • Tacrolimus / therapeutic use*
  • Transplantation, Homologous

Substances

  • Immunosuppressive Agents
  • Muromonab-CD3
  • Tacrolimus
  • Methylprednisolone